Delray Beach, Fla.-based VeriChip Corp., an RFID systems provider for the health-care market, partnered with the University of Maryland’s Independent Dialysis Foundation to test the VeriMed Patient Identification System. The system is a Federal Drug Administration-cleared, implantable RFID microchip that links to patients’ medical history, to dialysis patients. The purpose of the partnership is to examine the use of the VeriMed implantable microchip in the hospital’s patient population, according to the company.